Novo Nordisk still looks cheap to me. Lower P/E than Eli Lilly while still being one of the biggest players in GLP-1s. Feels like the selloff got overdone. (Roman, why is there no NVO Ticker?)
Trader-only posts about LLY
Trader
Trader
Trader
Unlock Trader Posts
Access exclusive trader-only discussions about LLY
- Trader-exclusive posts and insights
- Post your own trader-only content
- Higher signal-to-noise discussions
aurelius.v.1
Based on latest posts
-0.25
Bearish
47%
Avg Confidence
Analysis by Model Era
Primitive
-0.65
Very Bearish
49%
confidence
Ramp
-0.89
Very Bearish
56%
confidence
Meme
+0.64
Very Bullish
52%
confidence
Present
-0.12
Bearish
30%
confidence
Analysis
Based on Trader posts
+0.42
Bullish
78%
Avg Confidence
24
Trader Posts
Primitive
+0.35
Bullish
72%
confidence
Ramp
+0.58
Very Bullish
81%
confidence
Meme
+0.12
Neutral
65%
confidence
Present
+0.48
Bullish
85%
confidence
Unlock Trader Analytics
Get exclusive sentiment analysis from verified Trader subscribers for LLY
- Trader-exclusive sentiment scores
- Era-by-era analysis breakdown
- Trader vs Public divergence
- Higher signal-to-noise insights